Press Releases October 1, 2026 08:33 AM

Abhijit Dubey joins Roper Technologies Board of Directors

Roper Technologies strengthens board with AI and technology leadership expertise by adding Abhijit Dubey

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
ROP

Roper Technologies announced the appointment of Abhijit Dubey, CEO and Chief AI Officer of NTT DATA, to its Board of Directors. Dubey brings extensive experience in leading large global tech organizations and driving AI transformations. His insights are expected to support Roper's growth strategy in vertical market software and technology-enabled products.

Abhijit Dubey joins Roper Technologies Board of Directors
ROP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Abhijit Dubey joins Roper Technologies Board bringing AI and global technology leadership expertise.
  • Dubey’s background includes leadership roles at NTT DATA and McKinsey, emphasizing enterprise software, cloud computing, and AI-driven business transformation.
  • Roper continues to focus on vertical market software and technology-enabled products with an analytical approach towards acquisitions.

SARASOTA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that Abhijit Dubey has joined the Company's Board of Directors.

Mr. Dubey is Chief Executive Officer and Chief AI Officer of NTT DATA, Inc., a global business and technology services company. He also serves as a Director of NTT DATA Group Corporation, the publicly listed parent company of NTT DATA, Inc. In his current role, Mr. Dubey leads NTT DATA's strategy, growth, and operating performance, as well as the company's enterprise-wide AI strategy and its transformation toward an AI-native operating model.

Prior to his current role, Mr. Dubey served as Chairman and Global Chief Executive Officer of NTT Ltd. Before joining NTT, he spent more than 20 years at McKinsey & Company, including as a Senior Partner, where he was a core leader of the firm's global Technology, Media, and Telecommunications Practice and founded McKinsey's cloud computing practice.

“Abhijit's experience leading a large, global technology organization through an AI-driven transformation makes him a great fit for our Board,” said Neil Hunn, Roper Technologies' President and CEO. “His perspective on enterprise software, AI adoption, and scaling technology businesses globally will be a valuable addition as we continue to grow our portfolio of vertical market software and technology enabled product businesses.”

“Abhijit brings a rare combination of large-scale operating experience with technology and AI leadership to our Board,” said Amy Woods Brinkley, Roper Technologies' Board Chair. “We are confident that his background will support Roper's governance as we continue to execute on our long-term strategy.”

About Roper Technologies

Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 500. Roper has a proven, long-term track record of compounding cash flow and shareholder value. The Company operates market leading businesses that design and develop vertical software and technology enabled products for a variety of defensible niche markets. Roper utilizes a disciplined, analytical, and process-driven approach to redeploy its excess capital toward high-quality acquisitions. Additional information about Roper is available on the Company’s website at www.ropertech.com.

Contact information:
Investor Relations
941-556-2601
[email protected]


Risks

  • Integration and strategic alignment risks related to incorporating new leadership perspectives within Roper’s governance.
  • Execution risks in leveraging AI technologies effectively across Roper’s portfolio to maintain competitive advantage.
  • Market volatility affecting technology and software sectors that could impact Roper’s growth and acquisition plans.

More from Press Releases

Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A) Oct 2, 2026 Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 Oct 1, 2026 New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program Oct 1, 2026 FEMSA Schedules Conference Call to Discuss Third Quarter Financial Results Oct 1, 2026 Exodus Brings Stablecoins to Everyday Commerce, Starting With DIRECTV’s DGO Oct 1, 2026